An aging population, a squeezed public purse, inflated expectations, expanding chronic conditions, opportunities in emerging markets, and a focus on holistic therapies and patient outcomes, requires engaging diverse stakeholders. The opportunities and challenges in the healthcare sector are unprecedented. New technologies are disrupting the status quo, as digital platforms transform patient empowerment and care.
Consider wearable tech as an alternative or a support to a drug based solution and you’ll appreciate the power of the on-going, integrated mosaic of relationships and treatments with a real-time diagnostic dimension. This is all thanks to platforms that capture and disseminate data. Indeed, hello to the happy union of big data and personal data. Therapies based around the individual’s personal genome are emerging and creating new players and new business models.
Patients and carers are also more empowered, whether through legislation or access to information on the web and social channels. Concepts that seemed alien at one time, like transhumanism, where technology and human biology converge into a one symbiotic state to improve health or ability, now seem less fantastical.
For pharma and healthcare providers to leverage opportunities in this dynamic environment requires the engagement and coordination of multiple stakeholders. Very often there’s a need to see life from the perspective of other stakeholders. To reframe. This is one of the many ways we’re working with clients in healthcare, creating sales and leadership conferences, meetings and road shows, to deliver interactive and immersive experiences. Experiences that drive collaboration and the adoption of new thinking in pharma and medical product companies.
For reasons of confidentiality, we’re unable to share the names of our clients in the pharma and medical sector.
April 15, 2020